Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride may help shrink prostate cancer tumors.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Certain natural compounds called terpenes may help prevent prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Finasteride treats hair loss and reduces prostate cancer risk.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.